PFBT
SCLN

Parkside Financial Bank & Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28
Closed – – 1649
2017
Q1 		$0 Hold
28
– – ﹤0.01% 1622
2016
Q4 		$0 Buy
+28
New +$280 ﹤0.01% 1566

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkside Financial Bank & Trust's SCLN Position: Q2 2017 in Review

Parkside Financial Bank & Trust sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017, closing a stake of 28 shares.

Parkside Financial Bank & Trust first reported a position in SCLN in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2017. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • Parkside Financial Bank & Trust reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 28 Sciclone Pharmaceuticals Inc shares in Q2 2017.
  • Parkside Financial Bank & Trust first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 2 quarters.
  • Parkside Financial Bank & Trust's Sciclone Pharmaceuticals Inc position peaked at $0 in Q1 2017.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2017, filed 27 Jul 2017.